The Health Dose from Holland & Knight provides a weekly dose of legislative and regulatory insights to keep stakeholders informed about the latest developments in Washington, D.C. that affect the health sector. This week’s topics include updates on the FAA Reauthorization, the House passing the Congressional Budget Office Data Sharing Act, the Senate Committee on Finance releasing a discussion draft on drug shortages, and the House Ways and Means Committee preparing to mark up legislation to extend telehealth waivers.
FDA officials will be appearing before the Energy and Commerce Subcommittee, while there will be House and Senate hearings on administrative and regulatory burdens in healthcare. Last week, we saw hearings on cybersecurity threats, Medicaid and long-term services and supports, maternal mortality, workforce diversity, as well as Medicare and Social Security Trustees releasing their annual reports. Additionally, Departments of Health and Human Services, Labor, and Treasury have released cost-sharing FAQs.
This week’s updates also include HHS releasing draft guidance for the second cycle of the Medicare Drug Price Negotiation Program, FDA releasing Laboratory Developed Test Final Rule, finalizing of DACA health coverage rule. We also see MACPAC appointments are making headlines. For more information on these topics please read our full Health Dose report.